Caption Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.45M | Sell |
30,000
-272,100
| -90% | -$19.6M | 0.01% | 836 |
|
|
2026
Q1 | $20.6M | Buy |
302,100
+202,100
| +202% | +$14.3M | 0.12% | 179 |
|
|
2025
Q4 | $7.6M | Buy |
100,000
+40,000
| +67% | +$2.91M | 0.05% | 402 |
|
|
2025
Q3 | $3.68M | Buy |
60,000
+30,000
| +100% | +$1.56M | 0.03% | 599 |
|
|
2025
Q2 | $1.47M | Buy |
+30,000
| New | +$1.42M | 0.02% | 815 |
|
|
2024
Q3 | – | Sell |
-30,000
| Closed | -$917K | – | 1528 |
|
|
2024
Q2 | $917K | Hold |
30,000
| – | – | 0.01% | 684 |
|
|
2024
Q1 | $873K | Sell |
30,000
-130,200
| -81% | -$3.65M | 0.01% | 767 |
|
|
2023
Q4 | $4.42M | Buy |
160,200
+60,200
| +60% | +$1.38M | 0.06% | 377 |
|
|
2023
Q3 | $2.24M | Sell |
100,000
-38,200
| -28% | -$1.42M | 0.03% | 548 |
|
|
2023
Q2 | $5.62M | Buy |
+138,200
| New | +$6.76M | 0.1% | 247 |
|
|
2023
Q1 | – | Sell |
-168,400
| Closed | -$6.43M | – | 1458 |
|
|
2022
Q4 | $6.43M | Buy |
168,400
+138,400
| +461% | +$5.75M | 0.1% | 250 |
|
|
2022
Q3 | $1.51M | Hold |
30,000
| – | – | 0.02% | 732 |
|
|
2022
Q2 | $1.2M | Buy |
+30,000
| New | +$1.05M | 0.02% | 820 |
|
|
2022
Q1 | – | Sell |
-30,000
| Closed | -$1.2M | – | 1842 |
|
|
2021
Q4 | $1.2M | Hold |
30,000
| – | – | 0.01% | 976 |
|
|
2021
Q3 | $1.12M | Sell |
30,000
-60,000
| -67% | -$2.46M | 0.01% | 989 |
|
|
2021
Q2 | $3.81M | Buy |
+90,000
| New | +$3.86M | 0.05% | 450 |
|
|
2020
Q4 | – | Sell |
-30,000
| Closed | -$1.4M | – | 1200 |
|
|
2020
Q3 | $1.4M | Buy |
+30,000
| New | +$1.48M | 0.03% | 535 |
|
|
2020
Q1 | – | Sell |
-30,000
| Closed | -$1.44M | – | 1030 |
|
|
2019
Q4 | $1.44M | Hold |
30,000
| – | – | 0.05% | 426 |
|
|
2019
Q3 | $1.01M | Sell |
30,000
-38,000
| -56% | -$1.65M | 0.05% | 375 |
|
|
2019
Q2 | $3.06M | Buy |
68,000
+32,000
| +89% | +$1.26M | 0.15% | 185 |
|
|
2019
Q1 | $1.35M | Sell |
36,000
-14,000
| -28% | -$470K | 0.07% | 294 |
|
|
2018
Q4 | $1.72M | Hold |
50,000
| – | – | 0.14% | 201 |
|
|
2018
Q3 | $2.35M | Buy |
50,000
+32,500
| +186% | +$1.34M | 0.13% | 203 |
|
|
2018
Q2 | $591K | Buy |
+17,500
| New | +$546K | 0.05% | 302 |
|
Other funds holding PTCT
RI
JT
Caption Management's PTCT Position: Q3 2024 in Review
Caption Management sold out of PTC Therapeutics (PTCT) in Q3 2024, closing a stake of 6,300 shares — an estimated $193K sold.
Caption Management first reported a position in PTCT in Q2 2018 and held it in 11 quarters. The position peaked at $5.24M in Q4 2019. 203 funds tracked by Wall St. Rank hold PTCT as of Q3 2024.
- Caption Management reported no remaining PTC Therapeutics position as of Q3 2024 after selling out during the quarter.
- Caption Management sold 6,300 PTC Therapeutics shares in Q3 2024, an estimated $193K.
- Caption Management first reported a position in PTC Therapeutics in Q2 2018 and held it in 11 quarters.
- Caption Management's PTC Therapeutics position peaked at $5.24M in Q4 2019.
- 203 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2024.
Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.